Trial Profile
A study of R435(Bevacizmab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 May 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colon cancer
- Focus Therapeutic Use
- Sponsors Chugai Biopharmaceuticals
- 20 May 2016 New trial record